<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font19 { font-size : 19; } .font21 { font-size : 21; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font28 { font-size : 28; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">vaccine </span>
   <span class="font28">(). </span>
   <span class="font21">:–. </span>
   <span class="font19">vaccines </span>
   <span class="font17">Leishmania </span>
   <span class="font17">al.. </span>
   <span class="font16">human </span>
   <span class="font16">dogs </span>
   <span class="font15">visceral </span>
   <span class="font14">canine </span>
   <span class="font14">efficacy </span>
   <span class="font14">malaria </span>
   <span class="font14">Malaria </span>
   <span class="font14">Vaccine. </span>
   <span class="font14">vaccinated </span>
   <span class="font14">disease </span>
   <span class="font13">used </span>
   <span class="font13">(L.) </span>
   <span class="font13">Leishmune® </span>
   <span class="font13">leishmaniasis </span>
   <span class="font13">trial </span>
   <span class="font13">antigen </span>
   <span class="font13">clinical </span>
   <span class="font13">licensed </span>
   <span class="font13">infection </span>
   <span class="font13">response </span>
   <span class="font13">vaccination </span>
   <span class="font13">./j.vaccine... </span>
   <span class="font13">endemic </span>
   <span class="font13">parasite </span>
   <span class="font12">However, </span>
   <span class="font12">protection </span>
   <span class="font12">showed </span>
   <span class="font12">Phase </span>
   <span class="font12">composed </span>
   <span class="font12">cases </span>
   <span class="font12">diseases </span>
   <span class="font12">donovani </span>
   <span class="font12">incidence </span>
   <span class="font12">infantum </span>
   <span class="font12">{border-style </span>
   <span class="font12">Vaccines </span>
   <span class="font12">control </span>
   <span class="font12">falciparum </span>
   <span class="font12">leishmaniasis. </span>
   <span class="font12">parasites </span>
   <span class="font12">Plasmodium </span>
   <span class="font12">RTS,S </span>
   <span class="font12">blood </span>
   <span class="font12">live </span>
   <span class="font12">px;} </span>
   <span class="font12">use </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">children </span>
   <span class="font11">development </span>
   <span class="font11">high </span>
   <span class="font11">safety </span>
   <span class="font11">severe </span>
   <span class="font11">Available </span>
   <span class="font11">III </span>
   <span class="font11">Med </span>
   <span class="font11">fact, </span>
   <span class="font11">phase </span>
   <span class="font11">recombinant </span>
   <span class="font11">transmission </span>
   <span class="font11">Immunol. </span>
   <span class="font11">at: </span>
   <span class="font11">online </span>
   <span class="font11">promoted </span>
   <span class="font11">started </span>
   <span class="font11">surface </span>
   <span class="font11">using </span>
   <span class="font11">(), </span>
   <span class="font11">Furthermore, </span>
   <span class="font11">attenuated </span>
   <span class="font11">contrast, </span>
   <span class="font11">developed </span>
   <span class="font11">increase </span>
   <span class="font11">second </span>
   <span class="font11">(accessed </span>
   <span class="font11">.collab: </span>
   <span class="font11">:e. </span>
   <span class="font11">considered </span>
   <span class="font11">described </span>
   <span class="font11">hydrolase </span>
   <span class="font11">new </span>
   <span class="font11">protein </span>
   <span class="font11">study </span>
   <span class="font11">years </span>
   <span class="font11">./fimmu.. </span>
   <span class="font11">FML </span>
   <span class="font11">IgG </span>
   <span class="font11">Leishtec® </span>
   <span class="font11">Trop </span>
   <span class="font11">Vaccine </span>
   <span class="font11">ZVL </span>
   <span class="font11">antibodies </span>
   <span class="font11">area </span>
   <span class="font11">deaths </span>
   <span class="font11">immune </span>
   <span class="font11">infected </span>
   <span class="font11">preventive </span>
   <span class="font11">./S-()- </span>
   <span class="font11">DNA </span>
   <span class="font11">Infect </span>
   <span class="font11">adjuvants </span>
   <span class="font11">antigens </span>
   <span class="font11">caused </span>
   <span class="font11">field </span>
   <span class="font11">immunity </span>
   <span class="font11">main </span>
   <span class="font11">stage </span>
   <span class="font11">synthetic </span>
   <span class="font11">trials </span>
   <span class="font11">Dis. </span>
   <span class="font11">IL- </span>
   <span class="font11">ONE. </span>
   <span class="font11">Therefore, </span>
   <span class="font11">Vet </span>
   <span class="font11">addition, </span>
   <span class="font11">antibody </span>
   <span class="font11">areas </span>
   <span class="font11">assay </span>
   <span class="font11">based </span>
   <span class="font11">detected </span>
   <span class="font11">dog </span>
   <span class="font11">early </span>
   <span class="font11">experimental </span>
   <span class="font11">global </span>
   <span class="font11">healthy </span>
   <span class="font11">inactivated </span>
   <span class="font11">research </span>
   <span class="font11">responses </span>
   <span class="font11">vaccine, </span>
   <span class="font11">veterinary </span>
   <span class="font10">'s, </span>
   <span class="font10">Parasitol. </span>
   <span class="font10">Rev </span>
   <span class="font10">adjuvant </span>
   <span class="font10">candidate </span>
   <span class="font10">disease. </span>
   <span class="font10">formulation </span>
   <span class="font10">highly </span>
   <span class="font10">immunogenicity </span>
   <span class="font10">infections </span>
   <span class="font10">leishmania </span>
   <span class="font10">leishmaniasis: </span>
   <span class="font10">mice </span>
   <span class="font10">modern </span>
   <span class="font10">performed </span>
   <span class="font10">prevention </span>
   <span class="font10">protective </span>
   <span class="font10">proteins </span>
   <span class="font10">px; </span>
   <span class="font10">reduction </span>
   <span class="font10">results </span>
   <span class="font10">saponaria </span>
   <span class="font10">sporozoites </span>
   <span class="font10">studies </span>
   <span class="font10">vaccine. </span>
   <span class="font10">vaccines. </span>
   <span class="font10">{font-family </span>
   <span class="font10">(Table </span>
   <span class="font10">./journal.pone. </span>
   <span class="font10">FML-saponin </span>
   <span class="font10">Leishmaniasis </span>
   <span class="font10">Letifend® </span>
   <span class="font10">PEV </span>
   <span class="font10">Quillaja </span>
   <span class="font10">TBV </span>
   <span class="font10">and, </span>
   <span class="font10">assays </span>
   <span class="font10">cause </span>
   <span class="font10">cells </span>
   <span class="font10">controlled </span>
   <span class="font10">effective </span>
   <span class="font10">epidemiological </span>
   <span class="font10">font-size </span>
   <span class="font10">generation </span>
   <span class="font10">humans </span>
   <span class="font10">important </span>
   <span class="font10">increased </span>
   <span class="font10">induce </span>
   <span class="font10">infection. </span>
   <span class="font10">insect </span>
   <span class="font10">known </span>
   <span class="font10">low </span>
   <span class="font10">major </span>
   <span class="font10">natural </span>
   <span class="font10">observed </span>
   <span class="font10">obtained </span>
   <span class="font10">order </span>
   <span class="font10">positive </span>
   <span class="font10">pre-erythrocytic </span>
   <span class="font10">prevent </span>
   <span class="font10">saponin </span>
   <span class="font10">saponins </span>
   <span class="font10">vaccines, </span>
   <span class="font10">virus </span>
   <span class="font10">work </span>
   <span class="font10">(–). </span>
   <span class="font10">August </span>
   <span class="font10">Brazil </span>
   <span class="font10">Brazil. </span>
   <span class="font10">Brazilian </span>
   <span class="font10">CHMI </span>
   <span class="font10">Currently, </span>
   <span class="font10">FML-vaccine </span>
   <span class="font10">Giardia </span>
   <span class="font10">Licensed </span>
   <span class="font10">Nucleoside </span>
   <span class="font10">PCR </span>
   <span class="font10">September </span>
   <span class="font10">USA </span>
   <span class="font10">Vaccination </span>
   <span class="font10">agents </span>
   <span class="font10">anti-FML </span>
   <span class="font10">associated </span>
   <span class="font10">chagasi </span>
   <span class="font10">confirmed </span>
   <span class="font10">disease, </span>
   <span class="font10">double; </span>
   <span class="font10">following </span>
   <span class="font10">future </span>
   <span class="font10">hepatitis </span>
   <span class="font10">higher </span>
   <span class="font10">however, </span>
   <span class="font10">immunogenic </span>
   <span class="font10">induction </span>
   <span class="font10">infective </span>
   <span class="font10">injection </span>
   <span class="font10">inside </span>
   <span class="font10">malaria. </span>
   <span class="font10">mild </span>
   <span class="font10">nucleoside </span>
   <span class="font10">previously </span>
   <span class="font10">purified </span>
   <span class="font10">spite </span>
   <span class="font10">tested </span>
   <span class="font10">that, </span>
   <span class="font10">tool </span>
   <span class="font10">./S-X()- </span>
   <span class="font10">Africa </span>
   <span class="font10">BCG </span>
   <span class="font10">BSV </span>
   <span class="font10">Canileish® </span>
   <span class="font10">Chagas </span>
   <span class="font10">History </span>
   <span class="font10">Hyg. </span>
   <span class="font10">Malaria, </span>
   <span class="font10">Pfs </span>
   <span class="font10">Res. </span>
   <span class="font10">T-cell </span>
   <span class="font10">University </span>
   <span class="font10">achieved </span>
   <span class="font10">amastigotes </span>
   <span class="font10">blood-stage </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">called </span>
   <span class="font10">cell </span>
   <span class="font10">central </span>
   <span class="font10">century </span>
   <span class="font10">circumsporozoite </span>
   <span class="font10">combination </span>
   <span class="font10">conserved </span>
   <span class="font10">controls </span>
   <span class="font10">countries </span>
   <span class="font10">cure </span>
   <span class="font10">currently </span>
   <span class="font10">development. </span>
   <span class="font10">different </span>
   <span class="font10">does </span>
   <span class="font10">dogs. </span>
   <span class="font10">epitope </span>
   <span class="font10">epitopes </span>
   <span class="font10">evolution </span>
   <span class="font10">expected </span>
   <span class="font10">expressed </span>
   <span class="font10">formulations </span>
   <span class="font10">genetic </span>
   <span class="font10">guts </span>
   <span class="font10">heterologous </span>
   <span class="font10">host </span>
   <span class="font10">https://www.ncbi.nlm.nih.gov/pubmed/ </span>
   <span class="font10">immunotherapy </span>
   <span class="font10">include </span>
   <span class="font10">increases </span>
   <span class="font10">lamblia </span>
   <span class="font10">mortality </span>
   <span class="font10">mosquito </span>
   <span class="font10">murine </span>
   <span class="font10">pathogen </span>
   <span class="font10">pressure </span>
   <span class="font10">protect </span>
   <span class="font10">recently </span>
   <span class="font10">red </span>
   <span class="font10">reduce </span>
   <span class="font10">regions </span>
   <span class="font10">related </span>
   <span class="font10">review </span>
   <span class="font10">risk </span>
   <span class="font10">second-generation </span>
   <span class="font10">sequence </span>
   <span class="font10">shown </span>
   <span class="font10">signs </span>
   <span class="font10">solid; </span>
   <span class="font10">species </span>
   <span class="font10">sporozoite </span>
   <span class="font10">strong </span>
   <span class="font10">sustained </span>
   <span class="font10">symptoms </span>
   <span class="font10">transmission-blocking </span>
   <span class="font10">treatment </span>
   <span class="font10">type </span>
   <span class="font10">untreated </span>
   <span class="font10">vaccination, </span>
   <span class="font10">vaccination. </span>
   <span class="font10">worldwide </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">./.. </span>
   <span class="font10">./S-X()-X </span>
   <span class="font10">./ajtmh... </span>
   <span class="font10">./journal.pntd. </span>
   <span class="font10">./s--- </span>
   <span class="font10">Additionally, </span>
   <span class="font10">American </span>
   <span class="font10">Brazil, </span>
   <span class="font10">CP-S </span>
   <span class="font10">Clin </span>
   <span class="font10">Clinical </span>
   <span class="font10">DTH </span>
   <span class="font10">Dog </span>
   <span class="font10">Europe </span>
   <span class="font10">HPV </span>
   <span class="font10">Hence, </span>
   <span class="font10">IL-, </span>
   <span class="font10">Immunization </span>
   <span class="font10">Int </span>
   <span class="font10">Jenner </span>
   <span class="font10">Lancet </span>
   <span class="font10">Leishmune </span>
   <span class="font10">Leishmune®, </span>
   <span class="font10">LiESP/QA- </span>
   <span class="font10">ME-TRAP </span>
   <span class="font10">Microbiol. </span>
   <span class="font10">Negl </span>
   <span class="font10">Parasit </span>
   <span class="font10">Pasteur </span>
   <span class="font10">RTS,S/AS </span>
   <span class="font10">Recent </span>
   <span class="font10">Rio </span>
   <span class="font10">Safety </span>
   <span class="font10">Vectors. </span>
   <span class="font10">adjuvanted </span>
   <span class="font10">antigen, </span>
   <span class="font10">approach </span>
   <span class="font10">areas. </span>
   <span class="font10">autoclaved </span>
   <span class="font10">bacteria </span>
   <span class="font10">bacterial </span>
   <span class="font10">binding </span>
   <span class="font10">biological </span>
   <span class="font10">bite </span>
   <span class="font10">blocking </span>
   <span class="font10">bold </span>
   <span class="font10">bone </span>
   <span class="font10">candidates </span>
   <span class="font10">case </span>
   <span class="font10">challenge </span>
   <span class="font10">complete </span>
   <span class="font10">complex </span>
   <span class="font10">component </span>
   <span class="font10">concerns </span>
   <span class="font10">contributed </span>
   <span class="font10">courier; </span>
   <span class="font10">current </span>
   <span class="font10">cycle </span>
   <span class="font10">dead </span>
   <span class="font10">decrease </span>
   <span class="font10">defined </span>
   <span class="font10">description </span>
   <span class="font10">did </span>
   <span class="font10">disclosed </span>
   <span class="font10">dogs, </span>
   <span class="font10">donovani. </span>
   <span class="font10">double-blind, </span>
   <span class="font10">effect </span>
   <span class="font10">em; </span>
   <span class="font10">epidemics. </span>
   <span class="font10">era </span>
   <span class="font10">eradication </span>
   <span class="font10">erythrocyte </span>
   <span class="font10">fed </span>
   <span class="font10">finally </span>
   <span class="font10">first-generation </span>
   <span class="font10">focused </span>
   <span class="font10">followed </span>
   <span class="font10">fused </span>
   <span class="font10">germs </span>
   <span class="font10">golden </span>
   <span class="font10">immunization </span>
   <span class="font10">induced </span>
   <span class="font10">induces </span>
   <span class="font10">infants </span>
   <span class="font10">infectious </span>
   <span class="font10">injected </span>
   <span class="font10">inoculation </span>
   <span class="font10">insects </span>
   <span class="font10">large </span>
   <span class="font10">leishmaniasis, </span>
   <span class="font10">levels </span>
   <span class="font10">limitations </span>
   <span class="font10">lipid </span>
   <span class="font10">mainly </span>
   <span class="font10">marrow </span>
   <span class="font10">membrane </span>
   <span class="font10">merozoites </span>
   <span class="font10">mosquitoes </span>
   <span class="font10">native </span>
   <span class="font10">naturally </span>
   <span class="font10">neglected </span>
   <span class="font10">parasitological </span>
   <span class="font10">pathogens </span>
   <span class="font10">patients </span>
   <span class="font10">pilot </span>
   <span class="font10">potential </span>
   <span class="font10">practice </span>
   <span class="font10">produced </span>
   <span class="font10">production </span>
   <span class="font10">protects </span>
   <span class="font10">protozoan </span>
   <span class="font10">pt;} </span>
   <span class="font10">raised </span>
   <span class="font10">randomized </span>
   <span class="font10">rate </span>
   <span class="font10">regarding </span>
   <span class="font10">remain </span>
   <span class="font10">repeat </span>
   <span class="font10">resistance </span>
   <span class="font10">response. </span>
   <span class="font10">responsible </span>
   <span class="font10">safe </span>
   <span class="font10">safety, </span>
   <span class="font10">sera </span>
   <span class="font10">significant </span>
   <span class="font10">smallpox </span>
   <span class="font10">strains </span>
   <span class="font10">subunit </span>
   <span class="font10">success </span>
   <span class="font10">transient </span>
   <span class="font10">vaccines: </span>
   <span class="font10">vectors </span>
   <span class="font10">volunteers </span>
   <span class="font10">year </span>
  </p>
 </body>
</html>
